- Cape businessman known for starting NARS dies at 49 (2/23/17)9
- Man shot by police ID'd; witness shares his side of story (2/17/17)31
- MSHP: McLendon shot in side; autopsy refutes witness account (2/19/17)23
- Apparent punch at girls basketball game propels lawmaker into action (2/21/17)4
- Business notebook: Owners ready to roll out the Barrel 131 (2/20/17)6
- Missouri bill would limit transgender school bathroom access (2/22/17)47
- Annual father-daughter dance provides some fun bonding time (2/19/17)1
- SoutheastHEALTH, Washington University School of Medicine announce collaboration (2/24/17)13
- City issues precautionary boil order near Arena Park (2/23/17)
- $22M bond issue would alter Jackson schools (2/22/17)12
FDA approves nicotine lozenge for smokers
WASHINGTON -- Smokers trying to quit will soon be able to try a nicotine-containing lozenge to help reduce their cigarette cravings.
The Food and Drug Administration approved GlaxoSmithKline's Commit lozenge for over-the-counter sales Thursday. It marks the first nicotine-containing lozenge to win the agency's approval.
The FDA last spring forced off the market nicotine lollipops that a number of pharmacists were manufacturing as an alternative to nicotine patches or gum for smoking cessation.
The FDA has maintained that smoking cessation products are drugs that require its approval to sell.
Another company, Star Scientific, sells a lozenge made of compressed tobacco that delivers a dose of nicotine equal to a cigarette. Because that product is sold not for smoking cessation but as an alternative to cigarettes when smokers can't puff -- such as during an airplane flight -- it argues the FDA can't regulate the product. At the request of attorneys general of 42 states, the FDA is reviewing that issue.
Glaxo's Commit lozenges come in varying amounts of nicotine. How long a smoker goes between cigarettes determines the recommended strength. Suck a lozenge when a craving quits, gradually lowering the number and strength ingested over a 12-week weaning period, the company says.
The lozenges, available without a prescription, will be available next month, in 72-lozenge packs for $39.95.